Clinical parameters | No. of cases | Relative GAS5 expression | ||
---|---|---|---|---|
 |  | Low | High | P valuea |
Age | Â | Â | Â | 0.500 |
>60Â years | 39 | 19 | 20 | Â |
≤60 years | 33 | 17 | 16 |  |
Gender | Â | Â | Â | 0.479 |
Male | 37 | 20 | 17 | Â |
Female | 35 | 16 | 19 | Â |
Smoking | Â | Â | Â | 0.151 |
Non-smoker | 42 | 18 | 24 | Â |
Smoker | 30 | 18 | 12 | Â |
Differentiation | Â | Â | Â | 0.03** |
Well | 26 | 14 | 12 | Â |
Moderate-Poor | 46 | 36 | 10 | Â |
Maximum diameter | Â | Â | Â | 0.03** |
<3Â cm | 26 | 14 | 12 | Â |
≥3 cm | 46 | 36 | 10 |  |
Lymphatic metastasis | Â | Â | Â | 0.131 |
Absent | 41 | 27 | 14 | Â |
Present | 31 | 25 | 6 | Â |
Distal metastasis | Â | Â | Â | 1.000 |
M0 | 68 | 34 | 34 | Â |
M1 | 4 | 2 | 2 | Â |
TNM stage | Â | Â | Â | 0.047** |
I–II | 51 | 32 | 19 |  |
III–IV | 21 | 18 | 3 |  |
CEA | Â | Â | Â | 0.583 |
Positive | 34 | 16 | 18 | Â |
Negative | 38 | 18 | 20 | Â |
CA19-9 | Â | Â | Â | 0.500 |
Positive | 39 | 19 | 20 | Â |
Negative | 33 | 17 | 16 | Â |
CA125 | Â | Â | Â | 0.577 |
Positive | 29 | 16 | 13 | Â |
Negative | 43 | 29 | 24 | Â |